In addition, these gallate-containing phenolic compounds may have therapeutic efficacy in treating AD by activating ERα/PI3K/Akt signaling and thereby increasing anti-amyloidogenic APP α-processing. This evidence concerns the gene AKT1 and Alzheimer disease.